InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,509.01
(
0.00%
)
US TECH 100
19,671.60
(
0.15%
)
Dow Jones
39,308.00
(
0.00%
)
Brent Oil
87.21
(
-0.14%
)
Bitcoin
55,184.71
(
-3.15%
)
Post# of 252488
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Titan V

Send PM Follow Ignore
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Titan V

Re: None

Friday, 11/02/2018 3:10:15 PM

Friday, November 02, 2018 3:10:15 PM

Post# of 252488

Sage's postpartum depression treatment wins efficacy vote

—FDA advisors voted 18-0 that Zulresso (brexanolone) was effective for treatment of postpartum depression.

—Kind of as expected, the panel isn't a fan of home infusion.

—An FDA decision is expected by December 19.

—SAGE remains halted from trade.



https://seekingalpha.com/news/3404883-sages-postpartum-depression-treatment-wins-efficacy-vote

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up